Delpha Capital Management’s Medifast MED Stock Holding History

Delpha Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-160	Closed	-$11K	–	772
2017 Q4	$11K	Buy	+160	New	+$10.6K	0.01%	1032

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Delpha Capital Management's MED Position: Q1 2018 in Review

Delpha Capital Management sold out of Medifast (MED) in Q1 2018, closing a stake of 160 shares — an estimated $11K sold.

Delpha Capital Management first reported a position in MED in Q4 2017 and held it in 1 quarter. The position peaked at $11K in Q4 2017. 225 funds tracked by Wall St. Rank hold MED as of Q1 2018.

Delpha Capital Management reported no remaining Medifast position as of Q1 2018 after selling out during the quarter.
Delpha Capital Management sold 160 Medifast shares in Q1 2018, an estimated $11K.
Delpha Capital Management first reported a position in Medifast in Q4 2017 and held it in 1 quarter.
Delpha Capital Management's Medifast position peaked at $11K in Q4 2017.
225 funds tracked by Wall St. Rank held Medifast as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.